The chronic hepatitis B is a chronic disease that requires long-term, standardized treatment and follow-up, and many people need to undergo antiviral therapy. The actual chronic hepatitis B patients receiving antiviral therapy should be reviewed, and what items should be reviewed?1. Liver function: including transaminases, bilirubin, albumin and other indicators, should be reviewed at least once every 3 months, so that you can understand the changes in liver function. The actual fact is that you will be able to find out how to get the most out of the actual situation. It is important to note that you should check the five hepatitis B including the hepatitis B surface antigen titer, because the hepatitis B surface antigen titer is a very important indicator to judge the antiviral effect and the development of hepatitis B. 3, hepatitis B virus quantification: also known as HBVDNA, there are generally two kinds of reagents to check, respectively, domestic reagents and imported reagents. Chronic hepatitis B patients receiving antiviral treatment, before starting antiviral treatment, it is best to check the HBVDNA of imported reagents with high sensitivity, in the course of treatment, if the HBVDNA turns negative once the domestic reagents are checked, the imported reagents should be used to check later, so that once there is any rebound in the quantification of hepatitis B virus, it can be found at the first time, so as not to delay the time of checking out and The disease is delayed. As for the review interval, if the HBVDNA turns negative, it will be reviewed once every six months, and if there is any change in the disease, the review interval will be adjusted according to the specific situation, and the interval may be shortened. 4. Fetoprotein: This is a marker of liver cancer. All chronic hepatitis B patients have the possibility of liver cancer, and the chance of liver cancer can be reduced through standardized antiviral treatment, but we still have to be alert to the occurrence of liver cancer, so we must review the fetoprotein regularly (usually once every six months). 5.Abdominal ultrasound: it should be reviewed once every six months. Check whether there is any occupancy in the liver, how the shape is, whether there is any change in the width of portal vein, splenic vein and the size of spleen. This is the indicator of liver lesions. 6, blood routine: for patients receiving interferon therapy, blood routine must be reviewed regularly, and the interval between reviews depends on the specific situation, in case the white blood cells are reduced to the extent that the interferon dose must be reduced or discontinued. The blood routine is also a test that can reflect the presence of early cirrhosis.7. Coagulation: This is an important indicator of the synthetic function of the liver, and it is usually possible to review it once every six months.